IL92557A0 - Neutrophil-activating peptide-2,its preparation and pharmaceutical compositions containing it - Google Patents
Neutrophil-activating peptide-2,its preparation and pharmaceutical compositions containing itInfo
- Publication number
- IL92557A0 IL92557A0 IL92557A IL9255789A IL92557A0 IL 92557 A0 IL92557 A0 IL 92557A0 IL 92557 A IL92557 A IL 92557A IL 9255789 A IL9255789 A IL 9255789A IL 92557 A0 IL92557 A0 IL 92557A0
- Authority
- IL
- Israel
- Prior art keywords
- neutrophil
- preparation
- pharmaceutical compositions
- compositions containing
- activating peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888828728A GB8828728D0 (en) | 1988-12-08 | 1988-12-08 | Neutrophil-stimulating activity i |
| GB898909681A GB8909681D0 (en) | 1989-04-27 | 1989-04-27 | Neutrophil-stimulating activity 1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL92557A0 true IL92557A0 (en) | 1990-08-31 |
Family
ID=26294713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL92557A IL92557A0 (en) | 1988-12-08 | 1989-12-06 | Neutrophil-activating peptide-2,its preparation and pharmaceutical compositions containing it |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5759533A (da) |
| JP (1) | JP3051160B2 (da) |
| KR (1) | KR910700260A (da) |
| AU (1) | AU634508B2 (da) |
| BE (1) | BE1003636A4 (da) |
| CA (1) | CA2004685A1 (da) |
| CH (1) | CH681625A5 (da) |
| DK (1) | DK188690A (da) |
| ES (1) | ES2047458A6 (da) |
| FI (1) | FI903931A0 (da) |
| FR (1) | FR2640142B1 (da) |
| GB (1) | GB2231872B (da) |
| GR (1) | GR1000455B (da) |
| IL (1) | IL92557A0 (da) |
| NL (1) | NL8921262A (da) |
| NZ (1) | NZ231652A (da) |
| PT (1) | PT92509A (da) |
| SE (1) | SE9002589L (da) |
| WO (1) | WO1990006321A1 (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3051160B2 (ja) * | 1988-12-08 | 2000-06-12 | ノバルティス・アクチエンゲゼルシャフト | 好中球活性化ペプチド‐２ |
| US6673893B1 (en) * | 1990-02-01 | 2004-01-06 | University Of South Florida | Leukocyte derived growth factor 2 |
| WO1991011515A2 (en) * | 1990-02-01 | 1991-08-08 | University Of South Florida | Leukocyte-derived growth factor |
| WO1993001826A1 (en) * | 1991-07-19 | 1993-02-04 | East Carolina University | Method of treating asthma |
| AU3071492A (en) * | 1991-11-15 | 1993-06-15 | University Of Pennsylvania | Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 |
| WO1994016070A1 (en) * | 1993-01-07 | 1994-07-21 | University Of South Florida | Leukocyte derived growth factors |
| US5786327A (en) | 1993-03-12 | 1998-07-28 | Gensci Regeneration Sciences Inc. | Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same |
| US5578569A (en) * | 1993-03-12 | 1996-11-26 | Tam; Cherk S. | Method of increasing bone growth |
| US6174995B1 (en) | 1994-08-23 | 2001-01-16 | Haodong Li | Human chemokines, CKβ4 and CKβ10/MCP-4 |
| US6458349B1 (en) | 1995-06-02 | 2002-10-01 | Human Genome Sciences, Inc. | Chemokine β-4 polypeptides |
| US6391589B1 (en) | 1994-08-23 | 2002-05-21 | Human Genome Sciences, Inc. | Human chemokine beta-10 mutant polypeptides |
| US5912232A (en) * | 1994-09-23 | 1999-06-15 | Board Of Regents Of The University Of Nebraska | Anti-inflammatory polypeptide antagonists of human I1-8 |
| US5880094A (en) * | 1995-06-07 | 1999-03-09 | Osteopharm Limited | Polypeptides that stimulate bone growth |
| US6117839A (en) * | 1995-06-07 | 2000-09-12 | Gensci Regeneration Sciences, Inc. | Bone stimulating factor |
| US6352973B1 (en) | 1995-06-07 | 2002-03-05 | Osteopharm Inc. | Bone stimulating factor |
| US6693081B2 (en) * | 1995-09-26 | 2004-02-17 | Osteopharm Inc. | Bone stimulating factor |
| US6290948B1 (en) * | 1996-05-14 | 2001-09-18 | Smithkline Beecham Corporation | Method of treating sepsis and ARDS using chamohine beta-10 |
| JP2001517422A (ja) * | 1997-09-25 | 2001-10-09 | アカデミス・ジーケンハイス・ベイ・デ・ウニフェルジテイト・ファン・アムステルダム | 単離したおよび組換えによる抗菌ペプチドトロンボシジン−１（ｔｃ−１）およびトロンボシジン−２（ｔｃ−２）またはその変異体 |
| GB9807721D0 (en) * | 1998-04-08 | 1998-06-10 | Chiron Spa | Antigen |
| EP1295943B1 (en) * | 2000-03-07 | 2009-06-03 | Japan Tobacco Inc. | Polypeptides having activity of stimulating neutrophils |
| US6815421B1 (en) | 2001-03-22 | 2004-11-09 | Osteopharm Inc. | Polypeptides for use in ameliorating effects of aging in mammals |
| EP1534752B1 (en) | 2002-05-01 | 2011-08-03 | Human Genome Sciences, Inc. | Antibodies that specifically bind to chemokine beta-4 |
| US7177246B2 (en) * | 2003-09-12 | 2007-02-13 | Hewlett-Packard Development Company, L.P. | Optical disk drive focusing apparatus using sum signal |
| MX361929B (es) | 2010-11-19 | 2018-12-19 | Eisai R&D Man Co Ltd Star | Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes. |
| KR101993316B1 (ko) * | 2017-04-11 | 2019-06-26 | 나민자 | 강아지 배변기 |
| KR102453406B1 (ko) | 2020-08-24 | 2022-10-11 | 연세흠 | 반려동물 배변수거기 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897348A (en) * | 1983-08-25 | 1990-01-30 | Sri International | Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof |
| DE3737703A1 (de) * | 1987-11-06 | 1989-05-18 | Ferring Arzneimittel Gmbh | Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum |
| US5026639A (en) * | 1988-01-14 | 1991-06-25 | Nippon Mining Company, Limited | Method to improve mRNA translation and use thereof for production of platelet factor-4 |
| JP3051160B2 (ja) * | 1988-12-08 | 2000-06-12 | ノバルティス・アクチエンゲゼルシャフト | 好中球活性化ペプチド‐２ |
-
1989
- 1989-11-17 JP JP2500533A patent/JP3051160B2/ja not_active Expired - Lifetime
- 1989-11-17 NL NL8921262A patent/NL8921262A/nl not_active Application Discontinuation
- 1989-11-17 WO PCT/EP1989/001389 patent/WO1990006321A1/en not_active Application Discontinuation
- 1989-11-17 KR KR1019900701733A patent/KR910700260A/ko not_active Application Discontinuation
- 1989-11-17 ES ES9050004A patent/ES2047458A6/es not_active Expired - Lifetime
- 1989-11-17 AU AU46556/89A patent/AU634508B2/en not_active Ceased
- 1989-11-17 CH CH2577/90A patent/CH681625A5/de not_active IP Right Cessation
- 1989-12-06 GR GR890100810A patent/GR1000455B/el unknown
- 1989-12-06 NZ NZ231652A patent/NZ231652A/en unknown
- 1989-12-06 IL IL92557A patent/IL92557A0/xx unknown
- 1989-12-06 CA CA002004685A patent/CA2004685A1/en not_active Abandoned
- 1989-12-06 PT PT92509A patent/PT92509A/pt not_active Application Discontinuation
- 1989-12-07 FR FR8916207A patent/FR2640142B1/fr not_active Expired - Fee Related
- 1989-12-08 BE BE8901313A patent/BE1003636A4/fr not_active IP Right Cessation
-
1990
- 1990-05-11 GB GB9011468A patent/GB2231872B/en not_active Expired - Lifetime
- 1990-08-07 DK DK188690A patent/DK188690A/da not_active Application Discontinuation
- 1990-08-07 SE SE9002589A patent/SE9002589L/xx not_active Application Discontinuation
- 1990-08-08 FI FI903931A patent/FI903931A0/fi not_active IP Right Cessation
-
1995
- 1995-06-06 US US08/471,817 patent/US5759533A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03503767A (ja) | 1991-08-22 |
| FR2640142B1 (fr) | 1994-09-23 |
| DK188690D0 (da) | 1990-08-07 |
| KR910700260A (ko) | 1991-03-14 |
| SE9002589D0 (sv) | 1990-08-07 |
| CA2004685A1 (en) | 1990-06-08 |
| AU634508B2 (en) | 1993-02-25 |
| NL8921262A (nl) | 1990-11-01 |
| AU4655689A (en) | 1990-06-26 |
| SE9002589L (sv) | 1990-08-07 |
| GR1000455B (el) | 1992-07-30 |
| NZ231652A (en) | 1993-02-25 |
| CH681625A5 (da) | 1993-04-30 |
| GR890100810A (en) | 1991-03-15 |
| GB9011468D0 (en) | 1990-08-29 |
| JP3051160B2 (ja) | 2000-06-12 |
| GB2231872B (en) | 1992-07-22 |
| DK188690A (da) | 1990-08-07 |
| ES2047458A6 (es) | 1994-02-16 |
| PT92509A (pt) | 1990-06-29 |
| WO1990006321A1 (en) | 1990-06-14 |
| US5759533A (en) | 1998-06-02 |
| BE1003636A4 (fr) | 1992-05-12 |
| FR2640142A1 (fr) | 1990-06-15 |
| FI903931A0 (fi) | 1990-08-08 |
| GB2231872A (en) | 1990-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL92557A0 (en) | Neutrophil-activating peptide-2,its preparation and pharmaceutical compositions containing it | |
| IL91129A0 (en) | Aminomethyloxooxazolidinyl arylbenzene derivatives,their preparation and pharmaceutical compositions containing them | |
| IL90245A0 (en) | Ethenediamine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL95155A0 (en) | 1h-indazole-3-carboxamides,their preparation and pharmaceutical compositions containing them | |
| IL95640A0 (en) | 1-cycloalkylpiperidines,their preparation and pharmaceutical compositions containing them | |
| IL95045A0 (en) | Thienodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL101380A0 (en) | Bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
| IL94556A0 (en) | Hydroxypropylamines,their preparation and pharmaceutical compositions containing them | |
| IL94082A0 (en) | 3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL90864A0 (en) | Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them | |
| IL98499A0 (en) | Aminobenzodiazepines,their preparation and pharmaceutical compositions containing them | |
| IL88989A (en) | 16-dehydro-vitamin d3 derivatives, their preparation and pharmaceutical compositions containing them | |
| IL89778A (en) | Unsaturated n-benzopyranyllactams, their preparation and pharmaceutical compositions containing them | |
| IL92710A0 (en) | 2-iminobenzothiazoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL88404A0 (en) | Neutrophil activating factor,its preparation and pharmaceutical compositions containing it | |
| IL89084A0 (en) | Benzodioxole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL91245A0 (en) | Benzopyranol derivatives,their preparation and pharmaceutical compositions containing them | |
| IL91709A0 (en) | Substituted thienopyrans,their preparation and pharmaceutical compositions containing them | |
| IL90002A0 (en) | Phosphonoalkylpurine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL92326A0 (en) | Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them | |
| IL90548A0 (en) | Antitumor antibiotic designated bu-3420t,its preparation and pharmaceutical compositions containing it | |
| IL102666A0 (en) | Quinolin-2-yl-methoxybenzyl-hydroxyureas,their preparation and pharmaceutical compositions containing them | |
| IL103926A0 (en) | Quinolylmethoxyphenyl-acetamides,their preparation and pharmaceutical compositions containing them | |
| IL93676A0 (en) | Anthracycline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL95563A0 (en) | Substituted amino-pyridines,their preparation and pharmaceutical compositions containing them |